Sequestration and homing of bone marrow-derived lineage negative progenitor cells in the lung during pneumococcal pneumonia by unknown
BioMed CentralRespiratory Research
ssOpen AcceResearch
Sequestration and homing of bone marrow-derived lineage 
negative progenitor cells in the lung during pneumococcal 
pneumonia
Hisashi Suzuki, James C Hogg and Stephan F van Eeden*
Address: The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul's Hospital, University of British Columbia, Room 
166, 1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada
Email: Hisashi Suzuki - hsuzuki-jpn@umin.ac.jp; James C Hogg - JHogg@mrl.ubc.ca; Stephan F van Eeden* - SVaneeden@mrl.ubc.ca
* Corresponding author    
Abstract
Background: Bone marrow (BM)-derived progenitor cells have been shown to have the potential
to differentiate into a diversity of cell types involved in tissue repair. The characteristics of these
progenitor cells in pneumonia lung is unknown. We have previously shown that Streptococcus
pneumoniae induces a strong stimulus for the release of leukocytes from the BM and these
leukocytes preferentially sequester in the lung capillaries. Here we report the behavior of BM-
derived lineage negative progenitor cells (Lin- PCs) during pneumococcal pneumonia using
quantum dots (QDs), nanocrystal fluorescent probes as a cell-tracking technique.
Methods: Whole BM cells or purified Lin- PCs, harvested from C57/BL6 mice, were labeled with
QDs and intravenously transfused into pneumonia mice infected by intratracheal instillation of
Streptococcus pneumoniae. Saline was instilled for control. The recipients were sacrificed 2 and 24
hours following infusion and QD-positive cells retained in the circulation, BM and lungs were
quantified.
Results: Pneumonia prolonged the clearance of Lin- PCs from the circulation compared with
control (21.7 ± 2.7% vs. 7.7 ± 0.9%, at 2 hours, P < 0.01), caused preferential sequestration of Lin-
PCs in the lung microvessels (43.3 ± 8.6% vs. 11.2 ± 3.9%, at 2 hours, P < 0.05), and homing of these
cells to both the lung (15.1 ± 3.6% vs. 2.4 ± 1.2%, at 24 hours, P < 0.05) and BM as compared to
control (18.5 ± 0.8% vs. 9.5 ± 0.4%, at 24 hours, P < 0.01). Very few Lin- PCs migrated into air
spaces.
Conclusion: In this study, we demonstrated that BM-derived progenitor cells are preferentially
sequestered and retained in pneumonic mouse lungs. These cells potentially contribute to the
repair of damaged lung tissue.
Background
Streptococcus pneumoniae is the most common cause of
community acquired pneumonia and is one of the lead-
ing causes of death worldwide [1-3]. In addition to the
local inflammatory response in the lung, pneumococcal
pneumonia also induces a systemic immune response [4],
which includes stimulation of the bone marrow (BM)
with subsequent release of neutrophils and monocytes
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Studies from our laboratory demonstrated that pneumo-
coccal pneumonia accelerates the transit time of both neu-
trophils and monocytes through the marrow and the
release of these cells into the circulation [5,6]. A signifi-
cant fraction of these newly released cells have immature
characteristics and preferentially sequester in pneumonic
regions of the lung [7].
The systemic inflammatory response induced by pneumo-
nia is also characterized by an increase in circulating pro-
inflammatory mediators [8-10], of which several (such as
G-CSF and GM-CSF) are known to release hematopoietic
stem cells from the BM [11,12]. Recent studies have
shown that these BM-derived stem cells or progenitor cells
have the ability to differentiate into cells that repopulate
damaged tissues in different organs such as the heart [13],
liver [14-16], brain [17] and lungs [18-21]. The majority
of these studies have used models of toxic, traumatic or
ischemic tissue injury, and showed engraftment of both
type II [20,21] and type I [19] pneumocytes from BM-
derived cells demonstrating the ability of these cells to
participate in structural repair of the lung following
injury. Therefore, we postulate that BM-derived progeni-
tor cells will preferentially sequester in pneumonia-
induced damaged lung tissue.
To test this hypothesis, we developed a novel labeling
technique using quantum dots (QDs), which are fluores-
cent nanocrystals, to trace and quantify these progenitor
cells in the lung. QDs have previously been used to label
live cells for long-term multicolor in vivo imaging [22].
These nanocrystals are taken into cells by endocytotic
pathways and the fluorescence of QDs persist intracellu-
larly for more than a week [23]. Using this novel cell track-
ing technique, we measured clearance of infused whole
BM cells (BMCs) and BM-derived lineage negative progen-
itor cells (Lin- PCs) from the circulation, their sequestra-
tion in the BM and lung, and their migration into
airspaces in a mouse model of pneumonia.
Methods
Animals
Female C57BL/6J mice (10–12 weeks old) were used as
donors and recipients. Mice were purchased from Jackson
Laboratory (Bar Harbor, ME) and maintained on a stand-
ard laboratory diet and housed in a controlled environ-
ment with a 12-hour light/dark cycle in the animal care
facility at Jack Bell Research Centre. All animal experi-
ments were approved by the Animal Care Committee,
University of British Columbia.
Pneumonia model
For each experiment, Streptococcus pneumoniae (serotype
49619, ATCC, Rockville, MD) was used. A suspension of
bacteria in saline at a concentration of 2.5 × 109 colony-
forming units (CFU)/ml was prepared based on its optical
density. Recipients were anesthetized with isoflurane and
their tracheas were exposed by a small incision in the ven-
tral portion of the neck. Bacterial suspension (250 µL/100
g body weight) was instilled into the trachea via a 28-
gauge needle. An equal amount of sterile saline was used
for control mice. The incision was sutured after the instil-
lation. Following instillation, their weight was daily
recorded and their behaviors, symptoms, and the condi-
tion of the wound were monitored twice a day until they
were sacrificed.
Isolation of BM cells
Femurs and tibias were removed from donors (unin-
fected, age-matched female C57BL/6J mice) and whole
BM cells (BMCs) were obtained by flushing the marrow
cavities with 10 ml phosphate-buffered saline (PBS) with
a 25-gauge needle. The BM components were dispersed by
repeated passage through a 10 ml syringe. The cells were
washed twice with PBS+2% fetal bovine serum (FBS) and
were filtered through 70 µm nylon mesh (BD Biosciences,
San Jose, CA).
Isolation of lineage negative progenitor cells
For the purified progenitor cell transfusion experiments,
lineage negative progenitor cells (Lin- PCs) were separated
from whole BMCs using a mouse progenitor cell enrich-
ment kit (StemCell Technologies, Vancouver, Canada).
Briefly, whole BMCs were incubated with assorted anti-
bodies including rat anti-mouse CD5, CD45R, Mac-1, Gr-
1, 7-4 and TER-119 that identify differentiated cells. After
repeated washings to remove excess antibodies, the cells
were incubated with magnetized microbeads that bind
and eliminate the antigen-bound antibodies. Unbound
Lin- PCs were purified by magnetic separation using
AutoMacs (Miltenyi Biotec Inc, Auburn, CA) as a negative
fraction under its "DEPLETES" program. The number of
Lin- PCs was counted on the Cell-Dyn system (Abbott
Laboratories, North Chicago, Il).
Labeling of donor cells with QDs
BMCs and Lin- PCs obtained from donor mice were
labeled with QDs (Qtracker 655 Cell Labeling Kit, Quan-
tum Dot Corporation, Hayward, CA) by incubating with
10 nM QD-labeling solution at 37°C for 60 minutes.
Cells were washed twice with PBS to remove the excess
QDs.
Transfusion of donor cells
Forty-eight hours following instillation of S. pneumoniae
or control vehicle into the mouse lung, BMCs (1.0 × 106
cells/200 µl) or Lin- PCs (0.5 × 106 cells/200 µl) were
transfused into the recipients via tail vein injection.Page 2 of 10
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Recipients were sacrificed at 2 or 24 hours after the cell
transfusion. Blood was collected from the abdominal
aorta with a 25-gauge needle. Femurs and tibias were
obtained to isolate BMCs. Lungs were harvested and lung
volume was measured by the water replacement method
after inflating with 10% neutral-buffered formalin at 20
cmH2O. Lungs were then fixed in 10% formalin for more
than 24 hours and each lung was cut into five slices for
paraffin embedment.
Flow cytometric analysis
Flow cytometric analysis was performed to determine the
amount of QD-positive donor cells in recipients' periph-
eral blood and BM. Mononuclear cells (MNCs) were puri-
fied from whole blood by density gradient centrifugation
with Histopaque-1077 (Sigma-Aldrich, St Louis, MO) at
400 g for 30 minutes. BMCs were isolated from femurs
and tibias as described above. Both MNCs and BMCs were
washed twice with PBS+2% FBS and were analyzed by a
flow cytometer (Epics XL-MCL, Beckman Coulter Inc.,
Fullerton, CA) using the Summit software (Version 3.1,
Cytomation Inc., Fort Collins, CO). Typically, 200,000
events for MNCs and 400,000 events for BMCs were
acquired and the frequency of QD-positive cells was
measured. The numbers of donor cells in circulation and
BM were calculated as follows:
Number of QD-labeled donor cells in circulation = Frac-
tion of donor cells in MNCs × fraction of MNCs × white 
blood cell count (/ml) × circulating blood volume (7 ml/
100 g body weight)
Number of QD-labeled donor cells in BM = Fraction of 
donor cells in BM × total number of BMCs
The number of BMCs harvested from 2 femurs and 2 tib-
ias was considered to represent 18.1% of total murine
marrow [24]. The results were shown as percentages of
total number of transfused donor cells.
Histological analysis and detection of donor cells
Thin sections (5 µm) of lung tissue were prepared from
paraffin-embedded blocks. Nuclei were stained with
Hoechst 33342 (Invitrogen, Carlsbad, CA). Briefly, slides
were incubated with diluted Hoechst 33342 solution (2
µg/ml) for 10 minutes at room temperature, followed by
two washes with PBS for 10 minutes. The sections were
coverslipped and examined using confocal microscopy
(SP2 AOBS Confocal Microscope, Leica Microsystems
GmbH, Germany) to detect QD-positive donor cells.
Morphometric evaluation of QD-labeled donor cells in 
lung
The number of QD-labeled donor cells in recipient's lung
was determined using a modification of the sequential
level stereologic analysis [25]. A point-counting grid was
placed over the images of lung slices taken at 4× magnifi-
cation. The number of points falling on parenchyma was
counted and its volume fraction (Vv) was estimated as fol-
lows:
For quantitation of QD-positive cells, 100 randomly
selected fields of lung parenchyma were photodocu-
mented from each mouse using confocal microscopy with
a 63× objective lens. The Vv of QD-positive cells was cal-
culated using a grid of 2025 (45 × 45) points superim-
posed onto the captured images. The density of the grid
and number of fields counted were determined to main-
tain the coefficient of error below 0.2. The number of QD-
labeled donor cells sequestered in the recipients' lung was
calculated as follows:
Number of QD-labeled donor cells sequestered in lung = 
Lung volume × Vv lung parenchyma × Vv QD-positive 
cells × k-1
where k is the average volume of a mouse BMC as deter-
mined by measurement of 100 BMCs.
Localization of the QD-positive cells (either in lung
parenchyma or in alveolar airspaces) was also recorded
during the cell counting.
Statistical analyses
All results were presented as mean ± standard error (SE).
Statistical significance was evaluated using the unpaired
Student's t-test for comparisons between two groups. Mul-
tiple comparisons were performed by one-way ANOVA
and Tukey's post-hoc test. P < 0.05 was considered statis-
tically significant. All statistical analyses were performed
using SPSS software (Version 10.1, SPSS Inc., Chicago, IL).
Results
Evaluation of QDs in donor cells
A representative image and an emission scan of QD-
labeled donor cells are shown in Figure 1A and 1B. Fluo-
rescent particles were detected within the cytoplasm of
donor cells and the emission spectra of these particles
peaked at 650 nm, thus confirming the identity and pres-
ence of QDs in the cells. The labeling efficiency of QDs in
whole BMCs (79.9 ± 3.4%) and Lin- PCs (75.5 ± 2.9%)
was measured by flow cytometry, as depicted in Figure 1C.
Vv parenchyma
Sum of the points on parenchyma
Sum of the to
=
tal pointsPage 3 of 10
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The number of QD-labeled donor cells, expressed as a
ratio of total injected cells, detected in the circulation at 2
and 24 hours post-transfusion is shown in Figure 2.
In the whole BMC transfusion model (Figure 2A), the pro-
portion of QD-labeled donor cells at 2 hours post-transfu-
sion was 3.3 ± 0.7% and 4.3 ± 0.7% in control and
pneumonia groups, respectively (P = 0.34). However, the
ratio of labeled cells in the pneumonia group significantly
decreased to 1.8 ± 0.3% at 24 hours, as compared to the
previous timepoint (P = 0.01). In the Lin- PC transfusion
model (Figure 2B), the amount of QD-labeled donor cells
was significantly higher in the pneumonia group as com-
pared to control (21.7 ± 2.7% vs. 7.7 ± 0.9%, P = 0.008)
at 2 hours following transfusion. By 24 hours post-trans-
fusion, the ratio of labeled cells significantly decreased to
3.4 ± 1.1% (P = 0.04) in the control group and to 2.1 ±
0.5% (P < 0.001) in the pneumonia group from 2 hours.
However, at 24 hours there was no significant difference
in the circulating Lin- PCs between the two groups (P =
0.29).
Homing of donor cells to the BM
The proportion of QD-labeled donor cells (fraction of
total injected cells) that sequestered and homed to the BM
is shown in Figure 3. In the whole BMC transfusion model
(Figure 3A), there was a trend towards increased homing
of QD-labeled donor cells into the BM in the pneumonia
animals as compared to control (7.7 ± 0.6% vs. 6.1 ±
0.5%, P = 0.09) at 2 hours post-transfusion. At 24 hours,
the proportion of QD-labeled cells in both control and
pneumonia animals were not different (6.5 ± 0.3% vs. 6.7
± 0.6%, P = 0.81). There was also no significant difference
between 2 and 24 hours post-transfusion in both groups.
In the Lin- PC transfusion model (Figure 3B), the propor-
tion of QD-labeled donor cells that were sequestered in
the BM at 2 hours post-transfusion was similar between
the control and pneumonia groups (10.1 ± 1.5% vs. 12.9
± 1.2%, P = 0.19). After 24 hours, the ratio of labeled cells
homing to the BM in the pneumonia group increased sig-
nificantly (18.5 ± 0.8%, P = 0.006) as compared to the 2
hour timepoint and the fraction of cells was also signifi-
cantly higher as compared to control (18.5 ± 0.8% vs. 9.5
± 0.4%, P < 0.001).
Sequestration of donor cells in recipient lungs
Figure 4 shows a QD-labeled donor cell in recipient lung
tissue as viewed using confocal microscopy with an emis-
sion signal peak of 650 nm.
Figure 5 shows the proportion of labeled donor cells,
expressed as a fraction of total injected cells, which were
sequestered in the lung. In the whole BMC transfusion
Characteristics of labeled donor cellsFigure 1
Characteristics of labeled donor cells. Isolated BM cells 
harvested from donor mice were labeled with QDs, which 
have an emission peak at 655 nm. A representative image 
illustrating a labeled cell emitting red fluorescence as 
observed under confocal microscopy is shown (A) and the 
red signal was confirmed as QDs by measuring their emission 
wavelength (B). Both the whole BM and Lin- progenitor cell 
populations were labeled with quantum dots and the labeling 
efficiency was 79.9 ± 3.4% and 75.5 ± 2.9%, respectively (C). 
Data is shown as mean ± SE, n = 5. Scale bar is 5 µm.Page 4 of 10
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Frequency of labeled donor cells in circulation. Blood 
was collected from recipients which were sacrificed at 2 or 
24 hours after cell transfusion. The frequency of labeled cells 
was measured by flow cytometry and the total number of 
labeled donor cells in recipients' circulation was calculated. 
The results are shown as percentages of total number of 
transfused donor cells. In the whole BM cell transfusion 
experiment (A), the proportion of donor cells at 2 hours 
post-transfusion was 3.3 ± 0.7% and 4.3 ± 0.7% in control 
and pneumonia groups, respectively (P = 0.34). However, the 
ratio of labeled cells in the pneumonia group significantly 
decreased to 1.8 ± 0.3% at 24 hours (P = 0.01). In the Lin- 
progenitor cell transfusion model (B), the proportion of 
labeled progenitor cells in the pneumonia group was signifi-
cantly higher than control (21.7 ± 2.7% vs. 7.7 ± 0.9%, P = 
0.008) at 2 hours. The percentage of donor cells in the circu-
lation in both the control and pneumonia groups decreased 
after 24 hours and the difference between the two groups 
was no longer significant at 24 hours post-transfusion. Data is 
shown as mean ± SE; n = 6 (control group for each time-
point) and n = 7 (pneumonia group for each timepoint). *P < 
0.05, **P < 0.01.
Frequency of labeled donor cells in bone marrowigur  3
Frequency of labeled donor cells in bone marrow. BM 
cells were harvested from recipients which were sacrificed at 
2 or 24 hours after the cell transfusion. The frequency of 
labeled cells was measured by flow cytometry and the total 
number of labeled donor cells in recipients' bone marrow 
was calculated. The results are shown as percentages of total 
number of transfused donor cells. In the whole BM cell trans-
fusion experiment (A), there was an upward trend in the 
pneumonia group as compared to control (7.7 ± 0.6% vs. 6.1 
± 0.5%, P = 0.09) at 2 hours post-transfusion, although by 24 
hours, the number of labeled cells equalized and there was 
no significant difference between the groups (P = 0.81). In the 
Lin- progenitor cell transfusion model (B), there was no sig-
nificant difference in the proportion of labeled cells between 
the control and pneumonia groups (10.1 ± 1.5% vs. 12.9 ± 
1.2%, P = 0.19) at 2 hours. After 24 hours, the ratio of donor 
cells in the pneumonia group increased significantly as com-
pared to control (P < 0.001) and the previous timepoint (P = 
0.006). Data is shown as mean ± SE; n = 6 (control group for 
each timepoint) and n = 7 (pneumonia group for each time-
point). **P < 0.01.
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sequestered in the pneumonia lungs as compared to con-
trol at 2 hours post-transfusion (32.6 ± 4.6% vs. 15.3 ±
1.8%, P = 0.007). By 24 hours, the number of labeled cells
remaining in the lung significantly decreased in controls
(4.1 ± 1.7%, P = 0.001) and in the pneumonia group (8.3
± 1.1%, P < 0.001) as compared to the previous timepoint
with no significant difference between the control and
pneumonia groups.
In the Lin- PC transfusion model (Figure 5B), significantly
more donor cells were sequestered in the pneumonia
lungs as compared to control at 2 hours post-transfusion
(43.3 ± 8.6% vs. 11.2 ± 3.9%, P = 0.03). After 24 hours, as
compared to 2 hours post-transfusion, the donor cells
remaining in the lung decreased in both the control (2.4
± 1.2%) and the pneumonia groups (15.1 ± 3.6%)
although the decrease was significant only in the latter (P
= 0.04). The percentage of donor cells remaining in the
lungs of the pneumonia group was still significantly
higher than the control group (P = 0.04) at this timepoint.
Migration of donor cells into alveolar air space in 
pneumonia lungs
We next investigated the localization of the labeled donor
cells in the pneumonia lungs and detected migration of
these cells into alveolar air spaces. In the whole BMC
transfusion model (Figure 6A), the percentage of donor
cells that migrated into the alveolar air space in pneumo-
nia lungs was 2.2 ± 1.2% and 18.7 ± 3.7% at 2 and 24
hours post-transfusion, respectively, and the difference
between the two timepoints was significant (P = 0.001).
In the Lin- PC transfusion model (Figure 6B), 1.7 ± 1.1%
and 3.1 ± 4.3% of donor cells were found in alveolar air
space of pneumonia lungs at 2 and 24 hours, respectively.
No significant difference was observed between the two
timepoints (P = 0.60).
Discussion
In this study, we demonstrated that both whole BMCs and
BM-derived Lin- PCs were sequestered (2 hours) in the
lung while the Lin- PCs were preferentially retained (24
hours) there during pneumococcal pneumonia. Further-
more, these progenitor cells also remained in the lung tis-
sues and rarely migrated into the alveolar air spaces,
suggesting that BM-derived progenitor cells sequester and
home to lung tissues. Several studies have shown
increased circulating progenitor cells in lung injury mod-
els [26-28], as well as the participation of progenitor cells
in the repair response of the lung [18-21]. We propose
that during infectious inflammation of the lung, these
BM-derived progenitor cells could contribute to either
lung inflammation and/or repair following lung infec-
tion.
We used QDs to label and trace donor cells in recipients.
QDs are highly luminescent semiconductor nanocrystals
(CdSe/ZnS-core/shell) and their surface chemistry is mod-
ified with peptides so that they can be delivered into cyto-
Labeled donor cells in recipient lungFigure 4
Labeled donor cells in recipient lung. A representative 
image of a QD-labeled donor cell (arrow) as detected in 
recipient's lung tissue under confocal microscopy (A). Blue 
denotes nuclei stained with Hoechst 33342, green is autoflu-
orescence from lung tissue, and red is emission signal from 
quantum dots. The graph (B) shows the wavelength and fluo-
rescence level of QDs on the labeled cell (circle) and lung tis-
sue (square). The sharp peak at 655 nm indicates that the 
emission from QDs is very distinct from the autofluores-
cence of lung tissue. Scale bar is 10 µm.Page 6 of 10
(page number not for citation purposes)
Respiratory Research 2008, 9:25 http://respiratory-research.com/content/9/1/25
Page 7 of 10
(page number not for citation purposes)
Frequency of labeled donor cells in lungigur  5
Frequency of labeled donor cells in lung. The total 
number of QD-positive donor cells sequestered in the whole 
lung was calculated by morphometric analysis. The results 
are shown as the donor cell proportion of total injected cells 
that were sequestered in the lung. In the whole BM cell 
transfusion model (A), significantly more donor cells were 
sequestered in the pneumonia lungs as compared to control 
(32.6 ± 4.6% vs. 15.3 ± 1.8%, P = 0.007) at 2 hours post-
transfusion. After 24 hours, the number of donor cells in lung 
significantly decreased in both groups, and the difference 
between the two groups was no longer significant. In the Lin- 
progenitor cell transfusion model (B), there was a signifi-
cantly higher number of donor cells sequestered in the pneu-
monia lungs as compared to control (43.3 ± 8.6% vs. 11.2 ± 
3.9%, P = 0.03) at 2 hours post-transfusion. After 24 hours, 
although the percentage of donor cells decreased in both 
groups, the ratio of donor cells in the pneumonia group was 
still significantly higher than control (15.1 ± 3.6% vs. 2.4 ± 
1.2%, P = 0.04). Data is shown as mean ± SE; n = 6 (control 
group for each timepoint) and n = 7 (pneumonia group for 
each timepoint). *P < 0.05, **P < 0.01.
Migration of labeled donor cells into alveolar air spaceFi ure 6
Migration of labeled donor cells into alveolar air 
space. In pneumonia lungs, the ratio of cells that migrated 
into alveolar air space was measured. The results are shown 
as the percentage of donor cells that migrated into air space 
out of the total number of donor cells sequestered in pneu-
monia lung. In the whole BM cell transfusion model (A), a sig-
nificantly higher number of donor cells migrated into the air 
space of pneumonia lungs at 24 hours post-transfusion as 
compared to 2 hours (18.7 ± 3.7% vs. 2.2 ± 1.2%, P = 0.001). 
In the Lin- progenitor cell transfusion model (B), no signifi-
cant difference was observed between the 2 and 24 hour 
timepoints (1.7 ± 1.1% vs. 3.1 ± 4.3%, P = 0.60). Data is 
shown as mean ± SE; n = 7. **P < 0.01.
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over conventional organic fluorophores are their high lev-
els of brightness, resistance to photobleaching, wide range
of excitement wavelengths, and tunable fluorescent wave-
lengths depending on the size of the particles [29,30].
QDs are now widely used for cellular imaging and many
studies have shown the ability to trace diverse types of
cells following cell proliferation and differentiation for up
to a week without any effects on cell activation or cell
function [22,23,31]. We used whole BMCs and BM-
derived Lin- PCs and the labeling efficiency of QDs was
approximately 80% for both cell types (Figure 1C).
Although QDs may be cytotoxic to live cells due to their
reactive metal core [23], we used low QD concentrations
that have been shown to be noncytotoxic and have no
impact on cell function, such as cell proliferation and dif-
ferentiation [23]. Due to the brightness and high emission
signals of QDs, resistance to photobleaching and reten-
tion in labeled cells, we were able to clearly identify
labeled cells in the blood, BM and the lung using a com-
bination of flow cytometry and confocal microscopy.
Plett and colleagues have shown that BM-derived progen-
itor cells are rapidly cleared from the circulation after
transfusion [32]. In our study 92.3% of the transfused Lin-
PCs were cleared from recipient's circulation within 2
hours after the injection in control group. Interestingly,
this clearance from the circulation occurred much more
rapidly than those shown for transfusion of labeled neu-
trophils [33] or labeled monocytes [5]. Cell size and
deformability have been shown to be important in deter-
mining removal of infused cells from the circulation [34].
Immature BM-derived granulocytes are larger and less
deformable than mature granulocytes [35], and we
hypothesize that cell immaturity is responsible for the
rapid clearance of Lin- PCs from the circulation.
In the pneumonia model, however, the clearance of Lin-
PCs from the circulation at 2 hours following infusion
decreased (Figure 2). Interestingly, these findings are dif-
ferent from the results we have shown previously on neu-
trophils and monocytes. In bacterial infection,
neutrophils and monocytes are more rapidly cleared from
the circulation to be sequestered into the infected lungs
[6,36]. A unique and independent mechanism might exist
for the mobilization and sequestration of progenitor cells.
Increased number of circulating progenitor cells has been
shown in tissue injury animal models [26,27] as well as in
clinical settings including burn, post-cardiac surgery [37],
and pneumonia [28] patients. These findings suggest that
progenitor cells acquire the capability to remain in the cir-
culation during systemic inflammation for subsequent
sequestration into target organs upon demand. The rea-
son for this prolonged stay in the circulation is unclear
and needs further investigation. It could be that these cells
do not respond to chemo-attractants in the acute inflam-
matory milieu but are recruited later when cells for resolu-
tion and repair are required. Alternatively, these cells may
remain in the less hostile intravascular milieu to prolifer-
ate and mature, to home and migrate into the inflamma-
tory site at a stage when the acute inflammatory response
has been dampened.
Several studies have reported that BM-derived progenitor
cells accumulate in lung tissue and have the ability to
replace damaged cells following injury [18-21]. We show
here that significant sequestration of transfused Lin- PCs
occurred in pneumonic lungs at 2 hours as compared to
control lungs, suggesting preferential sequestration of
these cells in inflamed lung tissues. To determine homing
of BM-derived cells to inflamed lung tissues, we investi-
gated the localization of these cells at 24 hours after trans-
fusion. Using purified Lin- PCs, approximately 15.1% of
labeled cells were still in the lung at 24 hours while 2.1%
remained in the circulation, showing a 7 times enrich-
ment of Lin- PCs in the pneumonia lungs. Few of these
Lin- PCs migrated into the airspaces (approximately 3.1%
of all the cells remaining in the lung), therefore approxi-
mately 14.6% of the initially infused Lin- PCs homed to
lung tissues and were potentially available for lung tissue
regeneration and repair. These findings showed firstly that
very few progenitor cells migrate into the airspaces to par-
ticipate in airspace inflammation but the majority of cells
remain in the lung tissues where they have the potential,
via proliferation and differentiation, to participate in lung
structural repair. Secondly, a significant fraction of BM-
derived progenitor cells homed to the injured lung as
compared to the control lung. If this fraction of progenitor
cells that home to damaged lung regions remain constant
(as shown in the BM homing study by Szilvassy and col-
leagues [38]), increasing the number of infused progeni-
tor cells will increase the number of these cells that home
to injured lung tissues and become available for tissue
regeneration and repair.
Interestingly, in the present study, approximately 10–13%
of injected Lin- PCs, both in the control and pneumonia
groups, returned to the marrow at 2 hours, which sup-
ports previous work by other authors [32,38]. However,
more Lin-PCs homed back to the marrow at 24 hours in
pneumonia group (Figure 3B). This could represent the
marrow's ability to recruit progenitors from the circula-
tion pool during infection, in an attempt to produce addi-
tional inflammatory cells demanded from the BM by the
infection.
Conclusion
Our study showed that during pneumonia, BM-derived
lineage negative progenitor cells remain in the intravascu-
lar space for a prolonged time, preferentially sequester inPage 8 of 10
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over a short period of time (24 hours). These cells may
play an important role in inflammatory responses against
lung infection as well as contributing in tissue repair proc-
esses following the infection. Further studies will be
required to elucidate the mechanism of behavior of these
progenitor cells and to determine the phenotypic charac-
teristics of the cell type responsible for the tissue repara-
tion. Together these concepts may pave the way for future
novel cell-based therapy for lung tissue repair following
injury.
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